Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Universal Screening for Metabolic Dysfunction-Associated Liver Fibrosis in Primary Care: Evaluation of a Single-Step, Laboratory Informatión System-Driven Automated Case-Finding Strategy (LiverSeek)

NCT07658755 is registered in ClinicalTrials.gov with Hospital General Universitario Gregorio Marañon as lead sponsor.

NCT NCT07658755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07658755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Universal Screening for Metabolic Dysfunction-Associated Liver Fibrosis in Primary Care: Evaluation of a Single-Step, Laboratory Informatión System-Driven Automated Case-Finding Strategy (LiverSeek)
Lead sponsor
Hospital General Universitario Gregorio Marañon
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2024
Completion date
September 1, 2027
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver fibrosis, metabolic dysfunction-associated steatotic liver disease, non-alcoholic fatty liver disease nafld, obesity, obesity type 2 diabetes mellitus, type 2 diabetes mellitus